pH-responsive magnetic core-shell nanocomposites for drug delivery

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Polymer-modified nanoparticles offer triggered release of anticancer drugs like doxorubicin (DOX) for enhanced cancer therapy.
• Developing smart drug delivery systems that respond to tumor microenvironments is crucial for effective cancer treatment.

Purpose of the Study:

• To synthesize and characterize a pH-sensitive drug delivery system based on Fe3O4@mSiO2 core-shell nanocomposites functionalized with a poly(ethylene glycol) gatekeeper.
• To evaluate the drug retention and release properties of the nanocomposite system under different pH conditions relevant to tumor and normal tissues.
• To assess the cellular uptake and potential therapeutic applications of the synthesized nanocomposites in cancer treatment.

Main Methods:

• Synthesis of Fe3O4@mSiO2 core-shell nanocomposites (approx. 65 nm).
• Functionalization with a β-thiopropionate-poly(ethylene glycol) "gatekeeper" (P2) to create the Fe3O4@mSiO2@P2 drug carrier.
• Investigation of pH-sensitive drug release mechanisms due to β-thiopropionate linker hydrolysis under acidic conditions.
• Evaluation of cellular uptake by HeLa cells and assessment of biocompatibility and magnetic targeting capabilities.

Main Results:

• Successful synthesis of Fe3O4@mSiO2@P2 nanocomposites with pH-sensitive drug release capabilities.
• Demonstrated good drug retention before reaching the tumor site and triggered release in mildly acidic tumor environments.
• Observed rapid uptake by HeLa cells, attributed to small particle size and PEG modification, enhancing drug delivery efficiency.
• Exhibited excellent biocompatibility and magnetic targeting potential.

Conclusions:

• The Fe3O4@mSiO2@P2 nanocomposite system shows promising pH-sensitive drug release for cancer therapy.
• The system's ability to selectively release drugs in acidic tumor microenvironments and its efficient cellular uptake make it a valuable drug carrier.
• The combination of biocompatibility, selective release, and magnetic targeting suggests significant potential for future cancer treatment applications.